What is Syncom Formulation (India) Ltd. Quarterly Revenue?

Syncom Formulation (India) Ltd. Quarterly Revenue Syncom Formulation Jun-2026 Quarterly Revenue is Rs 132 Cr which is growth of 8.1% YoY.

What is Syncom Formulation (India) Ltd. Quarterly Net Profit?

Syncom Formulation (India) Ltd. Quarterly Net Profit Syncom Formulation Jun-2026 Quarterly Net Profit is Rs 25 Cr which is growth of 56.3% YoY.

What is Syncom Formulation (India) Ltd. Annual Revenue?

Syncom Formulation (India) Ltd. Annual Revenue Syncom Formulation Mar-2026 Annual Revenue is Rs 518 Cr which is growth of 7.8% YoY.

What is Syncom Formulation (India) Ltd. Annual Net Profit?

Syncom Formulation (India) Ltd. Annual Net Profit Syncom Formulation Mar-2026 Annual Net Profit is Rs 76 Cr which is growth of 55.5% YoY.

What is Syncom Formulation (India) Ltd. Total Shareholders Fund?

Syncom Formulation (India) Ltd. Total Shareholders Fund Syncom Formulation Mar-2025 Total Shareholders Fund is Rs 412 Cr which is growth of 21.3% YoY.

What is Syncom Formulation (India) Ltd. Total Assets?

Syncom Formulation (India) Ltd. Total Assets Syncom Formulation Mar-2025 Total Assets is Rs 529 Cr which is growth of 29.2% YoY.

What is Syncom Formulation (India) Ltd. Book Value Per Share?

Syncom Formulation (India) Ltd. Book Value Per Share Syncom Formulation Mar-2025 Book Value Per Share is 4 Rs which is growth of 21.3% YoY.

What is Syncom Formulation (India) Ltd. ROE?

Syncom Formulation (India) Ltd. ROE Syncom Formulation Mar-2025 ROE is 18% which is growth of 4.1% YoY.

What is Syncom Formulation (India) Ltd. Cash From Operating Activity?

Syncom Formulation (India) Ltd. Cash From Operating Activity Syncom Formulation Mar-2026 Cash From Operating Activity is Rs 58 Cr which is growth of 150.0% YoY.

What is Syncom Formulation (India) Ltd. Net Cash Flow?

Syncom Formulation (India) Ltd. Net Cash Flow Syncom Formulation Mar-2026 Net Cash Flow is Rs 4 Cr which is growth of 107.1% YoY.

Syncom Formulation (India) Ltd.

NSE: SYNCOMF | BSE: 524470

Strong Performer, Getting Expensive

Download real time

-0.54(-2.46%)

109.70% Gain from 52W Low

7.5M

NSE+BSE Volume

NSE 19 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Syncom Formulation quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Syncom Formulation quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Syncom Formulation Jun-2026 Quarterly Revenue is Rs 132 Cr which is growth of 8.1% YoY.
POSITIVE
Quarterly Net Profit Syncom Formulation Jun-2026 Quarterly Net Profit is Rs 25 Cr which is growth of 56.3% YoY.

Syncom Formulation (India) Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	132.5	148.2	120.1	126.7	122.6	155.4	130.9	105.7	88.1	76.1	67.7	66.4	61.2
SR_Q Operating Rev.	124.7	134	114.6	121.4	116.6	148.5	127	101.5	86.8	73.3	63.3	62.4	59.4
OI_Q Other Income	7.8	14.2	5.5	5.2	6	6.9	3.8	4.2	1.3	2.9	4.4	4	1.9
OEXPNS_Q Operating Exp.	98.8	112.5	93.4	102.7	100.8	131	112.4	89.6	76.4	64.5	56.5	56.3	53.2
OEXPNS_Q Operating Exp.	98.8	112.5	93.4	102.7	100.8	131	112.4	89.6	76.4	64.5	56.5	56.3	53.2
OP_Q Operating Profit	25.9	21.5	21.2	18.7	15.8	17.5	14.6	11.9	10.5	8.8	6.8	6.1	6.2
OPMPCT_Q Operating Profit Margin %	20.75%	16.03%	18.48%	15.42%	13.54%	11.77%	11.49%	11.75%	12.06%	12.02%	10.73%	9.76%	10.37%
DEP_Q Depr.	1.5	2.5	1.4	1.4	1.3	1.3	1.3	1.3	1.3	1.3	1.5	0.9	1.1
INT_Q Interest	0.2	0.4	0.3	0.3	0.2	0.1	0.2	0.2	0.4	1.2	1.1	1.1	1.1
PBT_Q Profit Before Tax	31.9	32.9	25.1	22.4	20.3	23	16.9	14.7	10.1	9.2	8.6	8.1	5.8
TAX_Q Tax	7.3	8.3	6.2	5.5	4.5	5.5	4.1	3.7	2.5	2.5	2.2	1.9	1.6
NP_Q Net Profit	24.6	24.6	18.9	16.8	15.7	17.5	12.8	11	7.6	6.8	6.4	6.2	4.3
EPS_adj_Q EPS Adj. latest	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1
NP_TTM Net profit TTM	84.9	76	68.9	62.9	57	48.9	38.1	31.8	27	23.6	25.3	23.1	20.5
EPS_TTM Basic EPS TTM	0.9	0.8	0.7	0.7	0.6	0.5	0.4	0.3	0.3	0.3	0.3	0.3	0.2
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Syncom Formulation competitor comparison and performance snapshot within industry

Syncom Formulation revenue mix: sales, profit, and capital employed breakups by segment

Syncom Formulation annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Syncom Formulation Mar-2026 Annual Revenue is Rs 518 Cr which is growth of 7.8% YoY.
POSITIVE
Annual Net Profit Syncom Formulation Mar-2026 Annual Net Profit is Rs 76 Cr which is growth of 55.5% YoY.

Syncom Formulation (India) Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	29.3%	15.5%	527.5	517.5	480	271.5	239.3	231.7	252	210.7	191.9	163.1	187.9	186.6
TotalOperatingRevenues_A Operating Rev. Ann.	29.4%	14.7%	494.7	486.6	462.9	258.4	224.6	219.7	244.8	205.5	186.8	158.6	184.8	183.9
OI_A Other Income Ann.	28.5%	34.3%	32.8	31	17.2	13.1	14.6	12	7.1	5.2	5.1	4.4	3.1	2.7
OEXPNS_A Operating Exp. Ann.	25.9%	14.6%	407.4	409.4	409.3	230.5	205	200.2	207	188.9	175	147	168.5	167.3
OEXPNS_A Operating Exp. Ann.	25.9%	14.6%	407.4	409.4	409.3	230.5	205	200.2	207	188.9	175	147	168.5	167.3
OP_A Operating Profit Ann.	57.9%	15.4%	87.2	77.2	53.5	27.9	19.6	19.5	37.8	16.6	11.8	11.7	16.4	16.6
OPMPCT_A OPM Ann. %	22.1%	-0.1%		14.91%	11.15%	10.26%	8.20%	8.40%	15.02%	7.90%	6.16%	7.16%	8.70%	8.90%
TotalExpenses_A Total Exp. Ann. ⌄	25.2%	14.6%		417.1	415.4	239.7	212.7	205.5	211.3	193.4	179.2	151	171.9	170.4
OtherExpenses_A Other Exp. Ann.	26.6%	23.7%	58.7	58.6	42.2	31.8	28.9	31.2	20.2	15.3	18.3	18.3	21.6	17.6
EmployeeBenefitExpenses_A Employee Exp. Ann.	37.3%	27.8%	68.3	67.1	52.2	35.1	25.9	22.2	19.7	16.3	15.6	15	14.5	13.6
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	46.8%	19.2%		108.1	70.7	41	34.2	31.5	45	21.9	16.9	16.1	19.4	19.3
EBIDTPCT_A EBITDA Ann. margin %	13.5%	3.2%		20.89%	14.73%	15.09%	14.30%	13.58%	17.85%	10.37%	8.81%	9.88%	10.34%	10.33%
INT_A Interest Ann.	-29.2%	29.7%	1.1	1.1	0.9	4.5	3.1	1.4	0.3	0.5	0.2	0.3	0.3	0.1
DEP_A Depr.	13%	10.2%	6.7	6.5	5.2	4.7	4.5	4	4	4.1	4	3.7	3.1	3
PBT_A PBT Ann.	55.8%	19.8%	112.2	100.5	64.7	31.8	26.6	26.2	40.7	17.3	12.7	12	16	16.2
TAX_A Tax Ann.	55.6%	16.3%	27.3	24.5	15.8	8.1	6.5	6.4	11.5	3	1.6	3.4	5.3	5.8
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	55.8%	21.1%		76	48.9	23.6	20.1	19.8	29.2	14.3	11.1	8.7	10.7	10.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	55.8%	21.1%	84.9	76	48.9	23.6	20.1	19.8	29.2	14.3	11.1	8.7	10.7	10.4
NETPCT_A NPM Ann. %	20.5%	5.6%		15.62%	10.55%	9.14%	8.93%	9.00%	11.91%	6.93%	5.93%	5.45%	5.76%	5.63%
EPS_adj_A EPS Adj. latest Ann.	58.7%	21.7%		0.8	0.5	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

7.8%

2Y CAGR

38.1%

3Y CAGR

29.3%

5Y CAGR

15.5%

7Y CAGR

15.2%

10Y CAGR

10.7%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

55.4%

2Y CAGR

79.5%

3Y CAGR

55.8%

5Y CAGR

21.1%

7Y CAGR

31.6%

10Y CAGR

22%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

2Y CAGR

33.3%

3Y CAGR

25.9%

5Y CAGR

14.6%

7Y CAGR

12.9%

10Y CAGR

9.4%

Operating Expenses Annual Cr growth is lower than historical averages.

Syncom Formulation balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Syncom Formulation Mar-2025 Total Shareholders Fund is Rs 412 Cr which is growth of 21.3% YoY.
POSITIVE
Total Assets Syncom Formulation Mar-2025 Total Assets is Rs 529 Cr which is growth of 29.2% YoY.

Syncom Formulation (India) Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	17.2%	17.1%	412.3	339.9	286.5	256	222.2	187.6	145.7	132.6	121.9	114.1	108.7
EQCAP_A Equity Share Capital Ann.	0%	3.5%	94	94	94	94	86.3	79	78.1	78.1	78.1	78.1	78.1
TotalShareCapital_A Total Share Capital Ann.	0%	3.5%	94	94	94	94	86.3	79	78.1	78.1	78.1	78.1	78.1
ReservesAndSurplus_A Reserves Plus Surplus Ann.	25.2%	26.4%	318.3	245.9	192.5	162	136	98.8	67.6	54.6	43.9	36.1	30.6
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	25.2%	26.4%	318.3	245.9	192.5	162	136	98.8	67.6	54.6	43.9	36.1	30.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	20.2%	15.3%	15.1	11.8	10	8.7	7.8	7.4	7.1	7.6	9.4	8.3	6.3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	22.6%	13%	8.1	6.3	5	4.4	4.6	4.4	4.2	5.6	7.5	7.2	5.9
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	2.2%	1.3%	1.6	1.3	1.7	1.5	1.5	1.5	1.7	1.2	1.2	0.6	0.4
CL_A Total Current Liabilities Ann. ⌄	-3.2%	1%	101.8	58	95.1	112.3	78.3	96.7	27.8	32.8	39.7	52.6	60.4
TradePayables_A Trade Payables Ann.	53.9%	20.5%	74.3	42.7	14.2	20.4	13.8	29.3	20.3	21.2	22.3	32.3	46.9
OtherCurrentLiabilities_A Other Current Liabilities Ann.	50%	46%	20.6	7.1	5.7	6.1	2.8	3.1	3.4	1.2	3.4	5.9	3.7
ShortTermProvisions_A ST Provisions Ann.	33.6%	23%	6.2	4.1	3.5	2.6	3.9	2.2	2	1.7	1.5	2.1	4.2
TL_A Total Capital Plus Liabilities Ann.	12%	12.7%	529.3	409.7	391.5	376.9	308.2	291.7	180.5	173	171	175.1	175.4
FixedAssets_A Fixed Assets Ann. ⌄	16.4%	14.9%	183.5	124.9	119.8	116.3	99.9	91.8	93.1	88.6	89.6	85	50.6
TangibleAssets_A Tangible Assets Ann.	61.8%	32.9%	183.1	77.5	72.3	43.2	46.5	44.2	45.9	48.2	57.4	54.9	45.8
IntangibleAssets_A Intangible Assets Ann.	26%	32%	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-				25.6	6.2	0.4			0.6	0.3	4.7
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	1.2%	14.8%	203.2	142.2	128.9	196.2	168.4	101.8	94	94.7	92.6	92.3	89.1
NonCurrentInvestments_A Non Current Investments Ann.	11%	16.7%	2.6	3.7	2.5	1.9	1.9	1.2	0.6	1.5	2	1.3	23.5
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-42.6%	109.8%		12.2	6.4	76.2	64.4	8	0.3	3.8	0.4	4	15.1
OtherNonCurrentAssets_A Other Non Current Assets Ann.	112.2%	84.7%	17.2	1.5	0.2	1.8	2.2	0.8		0.8	0.6	2.1
CA_A Total Current Assets Ann. ⌄	21.7%	11.4%	326	267.5	262.6	180.8	139.8	189.8	86.5	78.3	78.4	82.8	86.3
CurrentInvestments_A Current Investments Ann.	19.6%	60.8%	106.5	89.2	63.7	62.3	41.4	9.9
TradeReceivables_A Trade Receivables Ann.	12.7%	7.5%	107.6	106.9	93.2	75.1	67.6	74.8	43.3	41.3	37.7	46	46
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-16%	-39.7%	5.1	0.7	67.8	8.6	0.4	64.2	8.6	7.9	6.3	7.3	5.7
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	2.5%	10.2%	7	5.4	4.3	6.5	6	4.3	4.5		4		18.7
OtherCurrentAssets_A Other Current Assets Ann.	70.1%	21.2%	36.9	23.9	12.5	7.5	5	14.1	14	15.4	19.4	19.5	0.5
TA_A Total Assets Ann.	12%	12.7%	529.3	409.7	391.5	376.9	308.2	291.7	180.5	173	171	175.1	175.4
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	-	0.9	0.6	6.2	3	2.1	1.7				0.8
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-	-	57.5	57.5	57.5	56.8	56.8	55.8	55.8	55.8	55.8	55.8
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	-	3.7	2.5	1.9	1.9	1.2	0.6	1.5	2	1.3	17.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

29.2%

2Y CAGR

16.3%

3Y CAGR

12%

5Y CAGR

12.7%

7Y CAGR

17.3%

10Y CAGR

11.7%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

75.5%

2Y CAGR

3.5%

3Y CAGR

-3.2%

5Y CAGR

7Y CAGR

17.6%

10Y CAGR

5.4%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

21.3%

2Y CAGR

20%

3Y CAGR

17.2%

5Y CAGR

17.1%

7Y CAGR

17.6%

10Y CAGR

14.3%

Total ShareHolders Funds Annual growth is higher than historical averages.

Syncom Formulation ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Syncom Formulation Mar-2025 Book Value Per Share is 4 Rs which is growth of 21.3% YoY.
POSITIVE
ROE Syncom Formulation Mar-2025 ROE is 18% which is growth of 4.1% YoY.

Syncom Formulation (India) Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	17.7%	12.9%	4.4	3.6	3.1	2.7	2.6	2.4	1.9	1.7	1.6	1.5	1.4
ROA_A RoA Ann. %	39.2%	7.5%	14.36%	11.92%	6.03%	5.32%	6.42%	10.00%	7.89%	6.41%	5.05%	6.08%	5.90%
ROE_A ROE Ann. %	33%	3.5%	18.43%	14.37%	8.24%	7.83%	8.90%	15.55%	9.78%	8.36%	7.09%	9.33%	9.52%
ROCE_A ROCE Ann. %	28.5%	2.5%	23.76%	18.62%	12.22%	11.21%	11.96%	21.00%	11.65%	9.19%	9.42%	13.31%	14.15%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	13.4%	3.9%	22.22%	15.27%	15.85%	15.23%	14.31%	18.37%	10.63%	9.04%	10.15%	10.51%	10.47%
PBITMargin_A EBIT Ann. Margin %	16.5%	4.5%	20.87%	14.15%	14.02%	13.21%	12.52%	16.72%	8.66%	6.90%	7.80%	8.82%	8.84%
PBTMargin_A PBT Ann. Margin %	20.4%	4.4%	20.65%	13.96%	12.29%	11.82%	11.91%	16.62%	8.41%	6.78%	7.57%	8.65%	8.81%
NETPCT_A NPM Ann. %	20.5%	5.6%	15.62%	10.55%	9.14%	8.93%	9.00%	11.91%	6.93%	5.93%	5.45%	5.76%	5.63%
ASETTO_A Asset Turnover Ann. %	12.6%	0%	1	1.2	0.7	0.7	0.7	1	1.2	1.1	0.9	1.1	1.2
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	26%	9.9%	3.2	4.6	2.8	1.6	1.8	2	3.1	2.4	2	1.6	1.4
QuickRatio_A Quick Ratio Ann.	22.9%	8.9%	2.6	3.9	2.5	1.4	1.5	1.7	2.5	2	1.7	1.4	1.2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-				0.1					0.2	0.2	0.2
EarningRetention_A Earning Retention Ann. %	-	-	-								78.85%	85.35%	84.93%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-								85.23%	88.67%	88.31%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-	-								85.23%	88.67%	88.31%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	15.3%	31.7%	963.8	1,549.7	1,054.7	629.2	974.2	242.8	49.8	85.1	81.9	159	174
EVPerNetSales_A EV Per Net Sales Ann.	-10.6%	14.9%	2	3.4	4.1	2.8	4.4	1	0.2	0.5	0.5	0.9	1
PBV_A Price To Book Value Adjusted	-14.7%	-11.6%	4.88	6.46	7.03	7.86	8.31	9.02	11.48	12.6	13.71	14.64	15.38
EVPerEBITDA_A EV Per EBITDA Ann.	-21.5%	10.5%	8.9	21.9	25.8	18.4	31	5.4	2.3	5	5.1	8.2	9
MarketCapPerSales_A Market Cap Per Sales Ann.	-7.2%	14.9%	2	3.3	4.1	2.5	4.2	1	0.3	0.5	0.5	0.8	1
RetentionRatios_A Retention Ratio Ann. %	-	-	-								78.84%	85.34%	84.92%
EYield_A Earnings Yield Ann.	-	0%	0.1	0	0	0	0	0.1	0.3	0.1	0.1	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	-	-		0	0.3	0.3	0.3	0.3	0	0.1	0.1	0.1	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

28.3%

2Y CAGR

49.6%

3Y CAGR

33%

5Y CAGR

3.5%

7Y CAGR

12%

10Y CAGR

6.8%

ROE Annual % is stable compared to historical averages.

RoA Ann. %

1Y CHG

20.5%

2Y CAGR

54.3%

3Y CAGR

39.2%

5Y CAGR

7.5%

7Y CAGR

12.2%

10Y CAGR

9.3%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

-30.4%

2Y CAGR

6.9%

3Y CAGR

26%

5Y CAGR

9.9%

7Y CAGR

4.2%

10Y CAGR

8.6%

Current Ratio Annual is falling faster than historical averages.

Syncom Formulation cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Syncom Formulation Mar-2026 Cash From Operating Activity is Rs 58 Cr which is growth of 150.0% YoY.
POSITIVE
Net Cash Flow Syncom Formulation Mar-2026 Net Cash Flow is Rs 4 Cr which is growth of 107.1% YoY.

Syncom Formulation (India) Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	77.1%	-	58.3	23.3	-5.9	10.5	16.3	-150.2	-0.5	4.3	-1.6	16.9	24.2
PBT_A PBT Ann.	55.8%	19.8%	100.5	64.7	31.8	26.6	26.2	40.7	17.3	12.7	12	16	16.2
INT_A Interest Ann.	-29.2%	29.7%	1.1	0.9	4.5	3.1	1.4	0.3	0.5	0.2	0.3	0.3	0.1
TAX_A Tax Ann.	55.6%	16.3%	24.5	15.8	8.1	6.5	6.4	11.5	3	1.6	3.4	5.3	5.8
CFI_A Cash from Investing Act. Ann.	-	-	-50.6	-18.4	83.8	-45	-27.1	75.5	1.4	2.4	-2.2	-8.4	-22.9
CFA_A Cash from Financing Act. Ann.	-	-	-3.2	-67.6	-15.4	35	8.3	72	0	-0.2	-2.1	-2.1	-2.4
NCF_A Net Cash Flow Ann. ⌄	106.5%	-	4.4	-62.7	62.5	0.5	-2.5	-2.7	0.9	6.6	-5.8	6.4	-1.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	32.6%	-38.9%	0.7	63.4	0.8	0.3	2.8	8.2	7.4	0.8	6.6	0.2	6.8
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	85.4%	-1.5%	5.1	0.7	63.4	0.8	0.3	5.5	8.2	7.4	0.8	6.6	5.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

150.2%

3Y CAGR

77.1%

7Y CAGR

45.1%

10Y CAGR

9.2%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Syncom Formulation investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

109.70% Gain from 52W Low

Syncom Formulation quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents